ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling

Inflammatory bowel diseases (IBD) are widespread inflammatory diseases that cause debilitating health problems including cancer. In this study, we show that ZnO nanoparticle (ZnONP) treatment has markedly dose-dependent effects on the remission of dextran sulfate sodium (DSS)-induced ulcerative coli...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 7; no. 1; p. 43126
Main Authors Li, Jinquan, Chen, Hanqing, Wang, Bing, Cai, Chengxu, Yang, Xu, Chai, Zhifang, Feng, Weiyue
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 24.02.2017
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Inflammatory bowel diseases (IBD) are widespread inflammatory diseases that cause debilitating health problems including cancer. In this study, we show that ZnO nanoparticle (ZnONP) treatment has markedly dose-dependent effects on the remission of dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. We demonstrate the mechanism involves the antioxidant and anti-inflammatory abilities of ZnONPs to suppress ROS and malondialdehyde (MDA) production; increase GSH level; suppress proinflammatory cytokines IL-1β and TNF-α and myeloperoxidase (MPO). The ZnONP treatment is able to activate the Nrf2 pathway in the cellular antioxidant defense system. The novel finding is that ZnONP combined with mesalazine (5-ASA) can enhance the therapeutic efficacy of 5-ASA in the treatment of DSS-induced colitis. Lastly, we found that ZnONP treatment can restore the changes in special colonic bacteria of DSS-mice while the drug 5-ASA cannot. These results indicate that ZnONPs can act as a medical additive for the therapy of IBD.
AbstractList Inflammatory bowel diseases (IBD) are widespread inflammatory diseases that cause debilitating health problems including cancer. In this study, we show that ZnO nanoparticle (ZnONP) treatment has markedly dose-dependent effects on the remission of dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. We demonstrate the mechanism involves the antioxidant and anti-inflammatory abilities of ZnONPs to suppress ROS and malondialdehyde (MDA) production; increase GSH level; suppress proinflammatory cytokines IL-1β and TNF-α and myeloperoxidase (MPO). The ZnONP treatment is able to activate the Nrf2 pathway in the cellular antioxidant defense system. The novel finding is that ZnONP combined with mesalazine (5-ASA) can enhance the therapeutic efficacy of 5-ASA in the treatment of DSS-induced colitis. Lastly, we found that ZnONP treatment can restore the changes in special colonic bacteria of DSS-mice while the drug 5-ASA cannot. These results indicate that ZnONPs can act as a medical additive for the therapy of IBD.Inflammatory bowel diseases (IBD) are widespread inflammatory diseases that cause debilitating health problems including cancer. In this study, we show that ZnO nanoparticle (ZnONP) treatment has markedly dose-dependent effects on the remission of dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. We demonstrate the mechanism involves the antioxidant and anti-inflammatory abilities of ZnONPs to suppress ROS and malondialdehyde (MDA) production; increase GSH level; suppress proinflammatory cytokines IL-1β and TNF-α and myeloperoxidase (MPO). The ZnONP treatment is able to activate the Nrf2 pathway in the cellular antioxidant defense system. The novel finding is that ZnONP combined with mesalazine (5-ASA) can enhance the therapeutic efficacy of 5-ASA in the treatment of DSS-induced colitis. Lastly, we found that ZnONP treatment can restore the changes in special colonic bacteria of DSS-mice while the drug 5-ASA cannot. These results indicate that ZnONPs can act as a medical additive for the therapy of IBD.
Inflammatory bowel diseases (IBD) are widespread inflammatory diseases that cause debilitating health problems including cancer. In this study, we show that ZnO nanoparticle (ZnONP) treatment has markedly dose-dependent effects on the remission of dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. We demonstrate the mechanism involves the antioxidant and anti-inflammatory abilities of ZnONPs to suppress ROS and malondialdehyde (MDA) production; increase GSH level; suppress proinflammatory cytokines IL-1β and TNF-α and myeloperoxidase (MPO). The ZnONP treatment is able to activate the Nrf2 pathway in the cellular antioxidant defense system. The novel finding is that ZnONP combined with mesalazine (5-ASA) can enhance the therapeutic efficacy of 5-ASA in the treatment of DSS-induced colitis. Lastly, we found that ZnONP treatment can restore the changes in special colonic bacteria of DSS-mice while the drug 5-ASA cannot. These results indicate that ZnONPs can act as a medical additive for the therapy of IBD.
ArticleNumber 43126
Author Li, Jinquan
Chen, Hanqing
Yang, Xu
Chai, Zhifang
Wang, Bing
Feng, Weiyue
Cai, Chengxu
Author_xml – sequence: 1
  givenname: Jinquan
  surname: Li
  fullname: Li, Jinquan
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), Section of Environmental Biomedicine, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, College of Life Sciences, Central China Normal University
– sequence: 2
  givenname: Hanqing
  surname: Chen
  fullname: Chen, Hanqing
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences (CAS)
– sequence: 3
  givenname: Bing
  surname: Wang
  fullname: Wang, Bing
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences (CAS)
– sequence: 4
  givenname: Chengxu
  surname: Cai
  fullname: Cai, Chengxu
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences (CAS), National Center for Nanoscience and Technology
– sequence: 5
  givenname: Xu
  surname: Yang
  fullname: Yang, Xu
  email: yanxgu@mail.ccnu.edu.cn
  organization: Section of Environmental Biomedicine, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, College of Life Sciences, Central China Normal University
– sequence: 6
  givenname: Zhifang
  surname: Chai
  fullname: Chai, Zhifang
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences (CAS)
– sequence: 7
  givenname: Weiyue
  surname: Feng
  fullname: Feng, Weiyue
  email: fengwy@ihep.ac.cn
  organization: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences (CAS)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28233796$$D View this record in MEDLINE/PubMed
BookMark eNptkt1uFSEQx4mpsbX2whcwJN5Yk7Uw7OeNiWn9Shp7Ub3xhnDY2T00u7AF9iTnNXxiWU_bHKskBJj5zZ-BmefkwDqLhLzk7B1noj4LHqdccCifkCNgeZGBADjY2x-SkxBuWBoFNDlvnpFDqEGIqimPyK-f9opaZd2kfDR6wECVjlQFGuZpcsm2QRrX6NW0pcbSi-vrzNh21tjSedDJ_ofQbjDRhIUYjUa62tJRGRvTNLan_Rzp2o3oQlQhYcq2yzVmk6KT-5vvgAbTWzWk4wvytFNDwJO79Zj8-PTx-_mX7PLq89fzD5eZLlgeM9SKNdjmqmbY8RpUXlYo-Iq1otRQKFAdY2UFvOW6Rt6sBIi2BV42oik5Y-KYvN_pTvNqxFajjV4NcvJmVH4rnTLyb481a9m7jSwE5KxYBN7cCXh3O2OIcjRB4zAoi24OktcVFFXDeJPQ14_QGzf79N5EJaCCCnKRqFf7GT2kcl-uBJztAO1dSIXvpDYx_aFbEjSD5EwuPSEfeiJFnD6KuBf9H_t2x4bE2B79XpL_wL8BICXH_A
CitedBy_id crossref_primary_10_1007_s11010_022_04638_3
crossref_primary_10_1139_cjpp_2017_0247
crossref_primary_10_21048_IJND_2024_61_3_44900
crossref_primary_10_5217_ir_2020_00124
crossref_primary_10_1007_s12011_024_04193_6
crossref_primary_10_3389_fphar_2024_1539363
crossref_primary_10_1177_0960327117751235
crossref_primary_10_1088_2752_5724_ada62b
crossref_primary_10_3390_biochem4030010
crossref_primary_10_2217_nnm_2018_0202
crossref_primary_10_3389_fnut_2022_992502
crossref_primary_10_1016_j_phymed_2022_154091
crossref_primary_10_1097_JBR_0000000000000078
crossref_primary_10_1016_j_jff_2018_01_014
crossref_primary_10_1155_2019_8396878
crossref_primary_10_3389_fmolb_2023_1121429
crossref_primary_10_1016_j_bioadv_2023_213503
crossref_primary_10_1080_02772248_2021_1941021
crossref_primary_10_3389_fphar_2019_01354
crossref_primary_10_3390_ijms20164061
crossref_primary_10_1007_s12274_021_3303_5
crossref_primary_10_1016_j_jconrel_2023_05_007
crossref_primary_10_1186_s12989_020_00349_z
crossref_primary_10_3389_fmicb_2024_1491727
crossref_primary_10_1371_journal_pone_0181634
crossref_primary_10_3390_antiox13111369
crossref_primary_10_2174_1567201820666230602164325
crossref_primary_10_1007_s12011_023_03715_y
crossref_primary_10_1016_j_cej_2022_139870
crossref_primary_10_1016_j_addr_2021_05_030
crossref_primary_10_3390_ijms21113956
crossref_primary_10_1038_s41565_021_01017_9
crossref_primary_10_1016_j_nantod_2021_101234
crossref_primary_10_1016_j_nantod_2019_05_008
crossref_primary_10_1016_j_taap_2024_116943
crossref_primary_10_1007_s12011_020_02444_w
crossref_primary_10_1080_17435390_2021_1919330
crossref_primary_10_1177_03946320221150720
crossref_primary_10_1016_j_jksus_2021_101817
crossref_primary_10_1155_2017_6742652
crossref_primary_10_1038_s41598_021_91226_y
crossref_primary_10_1080_17425247_2022_2043847
crossref_primary_10_2147_IJN_S310952
crossref_primary_10_2147_IJN_S502546
crossref_primary_10_1186_s12951_023_02246_x
crossref_primary_10_1021_acs_jafc_3c03195
crossref_primary_10_1016_j_jsps_2017_07_003
crossref_primary_10_1016_j_prp_2018_10_011
crossref_primary_10_1007_s11686_023_00728_4
crossref_primary_10_1016_j_biopha_2018_11_116
crossref_primary_10_1038_s41598_019_46671_1
crossref_primary_10_1155_2018_1813047
crossref_primary_10_4155_fmc_2018_0313
crossref_primary_10_3390_ani14131919
crossref_primary_10_1039_C8FO01939H
crossref_primary_10_3390_nu15194093
crossref_primary_10_1007_s00449_024_03047_8
crossref_primary_10_1007_s12035_018_0935_x
crossref_primary_10_1155_2018_1062562
crossref_primary_10_1155_2019_1415809
crossref_primary_10_1007_s12011_024_04108_5
crossref_primary_10_3390_ani12070812
crossref_primary_10_1039_D2FO01347A
crossref_primary_10_1007_s12011_022_03241_3
crossref_primary_10_1093_crocol_otaa001
crossref_primary_10_1016_j_etap_2021_103721
crossref_primary_10_3389_fnut_2022_821404
crossref_primary_10_1021_acsnano_2c05558
Cites_doi 10.2174/1381612043452901
10.1002/ibd.21377
10.1111/j.1365-2036.2009.04195.x
10.1007/978-1-4939-0679-6_18
10.1155/2010/586092
10.1007/s11051-007-9245-3
10.1023/A:1011032328064
10.1056/NEJMra0804647
10.1016/j.intimp.2014.08.025
10.1016/j.canlet.2012.11.053
10.1007/s10620-006-9622-2
10.1002/biof.1195
10.1016/j.mrfmmm.2010.03.007
10.1136/gut.2006.118646
10.1016/j.giec.2013.03.006
10.1111/j.1574-6968.2007.01012.x
10.1002/ibd.20465
10.1002/bdrb.20264
10.1016/j.bcp.2008.07.017
10.1158/0008-5472.CAN-06-3562
10.1093/jn/130.5.1344S
10.1016/j.clnu.2013.03.020
10.1016/0016-5085(90)90290-H
10.1002/ijc.22943
10.3389/fcimb.2014.00028
10.1038/nmat2859
10.1002/ibd.21462
10.1016/j.jep.2012.07.008
10.1016/j.procbio.2013.10.007
10.1016/j.mrfmmm.2009.09.007
10.1002/mc.22274
10.1016/S0022-3476(99)70086-7
10.3390/ijerph110605720
10.1371/journal.pone.0106937
10.1016/j.freeradbiomed.2012.08.568
10.1038/nature06005
10.1016/S0014-2999(02)01592-3
10.1016/j.exger.2007.10.013
10.1002/smll.201500136
10.1038/ajgsup.2012.4
10.1158/1940-6207.CAPR-08-0028
ContentType Journal Article
Copyright The Author(s) 2017
Copyright Nature Publishing Group Feb 2017
Copyright © 2017, The Author(s) 2017 The Author(s)
Copyright_xml – notice: The Author(s) 2017
– notice: Copyright Nature Publishing Group Feb 2017
– notice: Copyright © 2017, The Author(s) 2017 The Author(s)
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/srep43126
DatabaseName SpringerOpen Free (Free internet resource, activated by CARLI)
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database ProQuest
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef

Publicly Available Content Database
PubMed
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
ExternalDocumentID PMC5324050
28233796
10_1038_srep43126
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
NPM
7XB
8FK
AARCD
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
5PM
ID FETCH-LOGICAL-c504t-eca09ed4a80ef182a467e31b0d36c25a2af006721d1c8e19b323dd21693961003
IEDL.DBID M48
ISSN 2045-2322
IngestDate Thu Aug 21 13:47:14 EDT 2025
Fri Jul 11 09:54:20 EDT 2025
Wed Aug 13 06:32:12 EDT 2025
Wed Feb 19 02:42:56 EST 2025
Tue Jul 01 04:02:48 EDT 2025
Thu Apr 24 23:06:04 EDT 2025
Fri Feb 21 02:39:59 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c504t-eca09ed4a80ef182a467e31b0d36c25a2af006721d1c8e19b323dd21693961003
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/srep43126
PMID 28233796
PQID 1901727243
PQPubID 2041939
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5324050
proquest_miscellaneous_1872579019
proquest_journals_1901727243
pubmed_primary_28233796
crossref_citationtrail_10_1038_srep43126
crossref_primary_10_1038_srep43126
springer_journals_10_1038_srep43126
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-02-24
PublicationDateYYYYMMDD 2017-02-24
PublicationDate_xml – month: 02
  year: 2017
  text: 2017-02-24
  day: 24
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2017
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Xavier, Podolsky (CR6) 2007; 448
Abraham, Cho (CR1) 2009; 361
Wilson (CR9) 2010; 9
Iacucci, de Silva, Ghosh (CR32) 2010; 24
Osburn (CR15) 2007; 121
Khor (CR3) 2006; 66
Rezaie, Parker, Abdollahi (CR7) 2007; 52
Lee, Kang, Lee, Nho (CR12) 2013; 330
Vimala (CR23) 2014; 49
Wang (CR43) 2008; 10
Chen, Kunsch (CR13) 2004; 10
Trivedi, Jena, Kumar (CR14) 2015; 55
Lamprecht, Schäfer, Lehr (CR42) 2001; 18
Nagalingam, Kao, Young (CR30) 2011; 17
Okayasu (CR34) 1990; 98
Cooper, Murthy, Shah, Sedergran (CR44) 1993; 69
Khor (CR11) 2008; 1
Pandurangan, Saadatdoust, Hamzah, Ismail (CR28) 2015; 41
Neumann, Kiesslich (CR2) 2013; 23
Chen (CR41) 2015; 11
Massironi (CR21) 2013; 32
Hambidge (CR17) 2000; 130
Singh (CR37) 2014; 9
Ramasamy (CR27) 2011; 17
Gkouskou, Deligianni, Tsatsanis, Eliopoulos (CR31) 2014; 4
Ferguson (CR35) 2010; 690
CR8
Bhutta (CR19) 1999; 135
Dou (CR4) 2014; 23
Mishra (CR5) 2012; 143
Prasad (CR36) 2008; 43
Li (CR29) 2008; 76
CR22
Uriu-Adams, Keen (CR16) 2010; 89
Oteiza (CR18) 2012; 53
Lyakhovich, Gasche (CR26) 2010; 31
Isaacs, Herfarth (CR40) 2008; 14
Schroeder (CR33) 2007; 3
Kim, Cha, Surh (CR10) 2010; 690
Luk, Ko, Fung, Cho (CR20) 2002; 443
Sartor, Mazmanian (CR38) 2012; 1
Jones, Ray, Ranjit, Manna (CR25) 2008; 279
Nuding, Fellermann, Wehkamp, Stange (CR39) 2007; 56
Martirosyan, Schneider (CR24) 2014; 11
S Massironi (BFsrep43126_CR21) 2013; 32
M Hambidge (BFsrep43126_CR17) 2000; 130
TO Khor (BFsrep43126_CR3) 2006; 66
WO Osburn (BFsrep43126_CR15) 2007; 121
C Abraham (BFsrep43126_CR1) 2009; 361
I Okayasu (BFsrep43126_CR34) 1990; 98
TO Khor (BFsrep43126_CR11) 2008; 1
H Chen (BFsrep43126_CR41) 2015; 11
J Kim (BFsrep43126_CR10) 2010; 690
W Li (BFsrep43126_CR29) 2008; 76
N Jones (BFsrep43126_CR25) 2008; 279
BFsrep43126_CR22
W Dou (BFsrep43126_CR4) 2014; 23
KW Schroeder (BFsrep43126_CR33) 2007; 3
HH Luk (BFsrep43126_CR20) 2002; 443
Z Bhutta (BFsrep43126_CR19) 1999; 135
S Ramasamy (BFsrep43126_CR27) 2011; 17
A Lamprecht (BFsrep43126_CR42) 2001; 18
H Neumann (BFsrep43126_CR2) 2013; 23
LR Ferguson (BFsrep43126_CR35) 2010; 690
HS Cooper (BFsrep43126_CR44) 1993; 69
SK Mishra (BFsrep43126_CR5) 2012; 143
JY Uriu-Adams (BFsrep43126_CR16) 2010; 89
RB Sartor (BFsrep43126_CR38) 2012; 1
X-L Chen (BFsrep43126_CR13) 2004; 10
B Wang (BFsrep43126_CR43) 2008; 10
RJ Xavier (BFsrep43126_CR6) 2007; 448
BFsrep43126_CR8
BN Singh (BFsrep43126_CR37) 2014; 9
P Trivedi (BFsrep43126_CR14) 2015; 55
PI Oteiza (BFsrep43126_CR18) 2012; 53
A Martirosyan (BFsrep43126_CR24) 2014; 11
AK Pandurangan (BFsrep43126_CR28) 2015; 41
DS Wilson (BFsrep43126_CR9) 2010; 9
S Nuding (BFsrep43126_CR39) 2007; 56
K Vimala (BFsrep43126_CR23) 2014; 49
M Iacucci (BFsrep43126_CR32) 2010; 24
AS Prasad (BFsrep43126_CR36) 2008; 43
A Rezaie (BFsrep43126_CR7) 2007; 52
A Lyakhovich (BFsrep43126_CR26) 2010; 31
KK Gkouskou (BFsrep43126_CR31) 2014; 4
K Isaacs (BFsrep43126_CR40) 2008; 14
KM Lee (BFsrep43126_CR12) 2013; 330
NA Nagalingam (BFsrep43126_CR30) 2011; 17
21391286 - Inflamm Bowel Dis. 2011 Apr;17(4):917-26
25194678 - Int Immunopharmacol. 2014 Nov;23(1):170-8
10586170 - J Pediatr. 1999 Dec;135(6):689-97
22819687 - J Ethnopharmacol. 2012 Sep 28;143(2):524-32
11474782 - Pharm Res. 2001 Jun;18(6):788-93
19799917 - Mutat Res. 2010 Aug 7;690(1-2):12-23
18694732 - Biochem Pharmacol. 2008 Dec 1;76(11):1485-9
19923578 - N Engl J Med. 2009 Nov 19;361(21):2066-78
17456510 - Gut. 2007 Sep;56(9):1240-7
1688816 - Gastroenterology. 1990 Mar;98 (3):694-702
20645323 - Inflamm Bowel Dis. 2011 Feb;17(2):532-42
20151072 - Can J Gastroenterol. 2010 Feb;24(2):127-33
23735111 - Gastrointest Endosc Clin N Am. 2013 Jul;23(3):695-705
17178849 - Cancer Res. 2006 Dec 15;66(24):11580-4
21960801 - Gastroenterol Hepatol (N Y). 2007 Nov;3(11):878-9
8350599 - Lab Invest. 1993 Aug;69(2):238-49
12044810 - Eur J Pharmacol. 2002 May 17;443(1-3):197-204
20803691 - Birth Defects Res B Dev Reprod Toxicol. 2010 Aug;89(4):313-25
25598500 - Mol Carcinog. 2016 Mar;55(3):255-67
10801941 - J Nutr. 2000 May;130(5S Suppl):1344S-9S
19138955 - Cancer Prev Res (Phila). 2008 Aug;1(3):187-91
25545372 - Biofactors. 2015 Jan-Feb;41(1):1-14
23219897 - Cancer Lett. 2013 Apr 28;330(2):225-32
19891667 - Aliment Pharmacol Ther. 2010 Jan 15;31(2):202-9
18421762 - Inflamm Bowel Dis. 2008 Nov;14(11):1597-605
18054190 - Exp Gerontol. 2008 May;43(5):370-7
23602613 - Clin Nutr. 2013 Dec;32(6):904-10
15032691 - Curr Pharm Des. 2004;10(8):879-91
18081843 - FEMS Microbiol Lett. 2008 Feb;279(1):71-6
26097125 - Small. 2015 Sep 9;11(34):4366-78
17631644 - Int J Cancer. 2007 Nov 1;121(9):1883-91
25187953 - PLoS One. 2014 Sep 04;9(9):e106937
17404859 - Dig Dis Sci. 2007 Sep;52(9):2015-21
22960578 - Free Radic Biol Med. 2012 Nov 1;53(9):1748-59
20935658 - Nat Mater. 2010 Nov;9(11):923-8
24879486 - Int J Environ Res Public Health. 2014 May 28;11(6):5720-50
17653185 - Nature. 2007 Jul 26;448(7152):427-34
20223251 - Mutat Res. 2010 Aug 7;690(1-2):3-11
24616886 - Front Cell Infect Microbiol. 2014 Feb 28;4:28
References_xml – volume: 9
  start-page: 923
  year: 2010
  end-page: 928
  ident: CR9
  article-title: Orally delivered thioketal nanoparticles loaded with TNF-α–siRNA target inflammation and inhibit gene expression in the intestines
  publication-title: Nat Mater
– ident: CR22
– volume: 10
  start-page: 263
  year: 2008
  end-page: 276
  ident: CR43
  article-title: Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice
  publication-title: J Nanopart Res
– volume: 14
  start-page: 1597
  year: 2008
  end-page: 1605
  ident: CR40
  article-title: Role of probiotic therapy in IBD
  publication-title: Inflamm Bowel Dis
– volume: 135
  start-page: 689
  year: 1999
  end-page: 697
  ident: CR19
  article-title: Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials
  publication-title: J Pediatr
– volume: 3
  start-page: 878
  year: 2007
  end-page: 879
  ident: CR33
  article-title: Is Mesalamine Safe?
  publication-title: Gastroenterology & Hepatology
– volume: 448
  start-page: 427
  year: 2007
  end-page: 34
  ident: CR6
  article-title: Unravelling the pathogenesis of inflammatory bowel disease
  publication-title: Nature
– volume: 690
  start-page: 12
  year: 2010
  end-page: 23
  ident: CR10
  article-title: A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders
  publication-title: Mutat Res
– volume: 89
  start-page: 313
  year: 2010
  end-page: 325
  ident: CR16
  article-title: Zinc and reproduction: effects of zinc deficiency on prenatal and early postnatal development
  publication-title: Birth Defects Res Part B: Dev Reprod Toxicol
– volume: 43
  start-page: 370
  year: 2008
  end-page: 377
  ident: CR36
  article-title: Clinical, immunological, anti-inflammatory and antioxidant roles of zinc
  publication-title: Exp Gerontol
– volume: 130
  start-page: 1344S
  year: 2000
  end-page: 1349S
  ident: CR17
  article-title: Human Zinc Deficiency
  publication-title: The Journal of Nutrition
– volume: 4
  start-page: 28
  year: 2014
  ident: CR31
  article-title: The gut microbiota in mouse models of inflammatory bowel disease
  publication-title: Front Cell Infect Microbiol
– volume: 23
  start-page: 695
  year: 2013
  end-page: 705
  ident: CR2
  article-title: Endomicroscopy and endocytoscopy in IBD
  publication-title: Gastrointest Endosc Clin N Am
– volume: 330
  start-page: 225
  year: 2013
  end-page: 32
  ident: CR12
  article-title: Nuclear factor-E2 (Nrf2) is regulated through the differential activation of ERK1/2 and PKC alpha/betaII by Gymnasterkoreayne B
  publication-title: Cancer Lett
– volume: 17
  start-page: 917
  year: 2011
  end-page: 926
  ident: CR30
  article-title: Microbial ecology of the murine gut associated with the development of DSS-colitis
  publication-title: Inflamm Bowel Dis
– volume: 52
  start-page: 2015
  year: 2007
  end-page: 21
  ident: CR7
  article-title: Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?
  publication-title: Dig Dis Sci
– ident: CR8
– volume: 24
  start-page: 127
  year: 2010
  end-page: 133
  ident: CR32
  article-title: Mesalazine in inflammatory bowel disease: A trendy topic once again?
  publication-title: Can J Gastroenterol
– volume: 11
  start-page: 4366
  year: 2015
  end-page: 4378
  ident: CR41
  article-title: Coculture with Low-Dose SWCNT Attenuates Bacterial Invasion and Inflammation in Human Enterocyte-like Caco-2 Cells
  publication-title: Small
– volume: 98
  start-page: 694
  year: 1990
  end-page: 702
  ident: CR34
  article-title: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
  publication-title: Gastroenterology
– volume: 49
  start-page: 160
  year: 2014
  end-page: 172
  ident: CR23
  article-title: Green synthesized doxorubicin loaded zinc oxide nanoparticles regulates the Bax and Bcl-2 expression in breast and colon carcinoma
  publication-title: Process Biochem
– volume: 17
  start-page: 532
  year: 2011
  end-page: 542
  ident: CR27
  article-title: Intestinal Alkaline Phosphatase Has Beneficial Effects in Mouse Models of Chronic Colitis
  publication-title: Inflammatory bowel diseases
– volume: 69
  start-page: 238
  year: 1993
  end-page: 249
  ident: CR44
  article-title: Clinicopathologic study of dextran sulfate sodium experimental murine colitis
  publication-title: Lab Invest
– volume: 1
  start-page: 15
  year: 2012
  end-page: 21
  ident: CR38
  article-title: Intestinal Microbes in Inflammatory Bowel Diseases
  publication-title: Am J Gastroenterol
– volume: 55
  start-page: 255
  year: 2015
  end-page: 267
  ident: CR14
  article-title: Melatonin modulated autophagy and Nrf2 signaling pathways in mice with colitis‐associated colon carcinogenesis
  publication-title: Mol Carcinog
– volume: 279
  start-page: 71
  year: 2008
  end-page: 76
  ident: CR25
  article-title: Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms
  publication-title: FEMS Microbiol Lett
– volume: 32
  start-page: 904
  year: 2013
  end-page: 910
  ident: CR21
  article-title: Nutritional deficiencies in inflammatory bowel disease: Therapeutic approaches
  publication-title: Clin Nutr
– volume: 56
  start-page: 1240
  year: 2007
  end-page: 7
  ident: CR39
  article-title: Reduced mucosal antimicrobial activity in Crohn’s disease of the colon
  publication-title: Gut
– volume: 1
  start-page: 187
  year: 2008
  end-page: 91
  ident: CR11
  article-title: Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer
  publication-title: Cancer Prev Res (Phila)
– volume: 23
  start-page: 170
  year: 2014
  end-page: 178
  ident: CR4
  article-title: Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation
  publication-title: Int Immunopharmacol
– volume: 10
  start-page: 879
  year: 2004
  end-page: 891
  ident: CR13
  article-title: Induction of Cytoprotective Genes Through Nrf2/Antioxidant Response Element Pathway: A New Therapeutic Approach for the Treatment of Inflammatory Diseases
  publication-title: Curr Pharm Des
– volume: 31
  start-page: 202
  year: 2010
  end-page: 9
  ident: CR26
  article-title: Systematic review: molecular chemoprevention of colorectal malignancy by mesalazine
  publication-title: Aliment Pharmacol Ther
– volume: 76
  start-page: 1485
  year: 2008
  end-page: 9
  ident: CR29
  article-title: Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis
  publication-title: Biochem Pharmacol
– volume: 443
  start-page: 197
  year: 2002
  end-page: 204
  ident: CR20
  article-title: Delineation of the protective action of zinc sulfate on ulcerative colitis in rats
  publication-title: Eur J Pharmacol
– volume: 41
  start-page: 1
  year: 2015
  end-page: 14
  ident: CR28
  article-title: Dietary cocoa protects against colitis‐associated cancer by activating the Nrf2/Keap1 pathway
  publication-title: Biofactors
– volume: 143
  start-page: 524
  year: 2012
  end-page: 532
  ident: CR5
  article-title: Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice
  publication-title: J Ethnopharmacol
– volume: 18
  start-page: 788
  year: 2001
  end-page: 793
  ident: CR42
  article-title: Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
  publication-title: Pharm Res
– volume: 690
  start-page: 3
  year: 2010
  end-page: 11
  ident: CR35
  article-title: Chronic inflammation and mutagenesis
  publication-title: Mutat Res
– volume: 9
  start-page: e106937
  year: 2014
  ident: CR37
  article-title: Biosynthesis of Stable Antioxidant ZnO Nanoparticles by Rhamnolipids
  publication-title: PLoS ONE
– volume: 11
  start-page: 5720
  year: 2014
  end-page: 50
  ident: CR24
  article-title: Engineered nanomaterials in food: implications for food safety and consumer health
  publication-title: Int Environ Res Public Health
– volume: 121
  start-page: 1883
  year: 2007
  end-page: 1891
  ident: CR15
  article-title: Increased colonic inflammatory injury and formation of aberrant crypt foci in Nrf2-deficient mice upon dextran sulfate treatment
  publication-title: Int J Cancer
– volume: 361
  start-page: 2066
  year: 2009
  end-page: 78
  ident: CR1
  article-title: Mechanisms of Disease
  publication-title: N Engl J Med
– volume: 66
  start-page: 11580
  year: 2006
  end-page: 11584
  ident: CR3
  article-title: Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium–induced colitis
  publication-title: Cancer Res
– volume: 53
  start-page: 1748
  year: 2012
  end-page: 59
  ident: CR18
  article-title: Zinc and the modulation of redox homeostasis
  publication-title: Free Radic Biol Med
– volume: 10
  start-page: 879
  year: 2004
  ident: BFsrep43126_CR13
  publication-title: Curr Pharm Des
  doi: 10.2174/1381612043452901
– volume: 17
  start-page: 532
  year: 2011
  ident: BFsrep43126_CR27
  publication-title: Inflammatory bowel diseases
  doi: 10.1002/ibd.21377
– volume: 31
  start-page: 202
  year: 2010
  ident: BFsrep43126_CR26
  publication-title: Aliment Pharmacol Ther
  doi: 10.1111/j.1365-2036.2009.04195.x
– ident: BFsrep43126_CR8
  doi: 10.1007/978-1-4939-0679-6_18
– volume: 24
  start-page: 127
  year: 2010
  ident: BFsrep43126_CR32
  publication-title: Can J Gastroenterol
  doi: 10.1155/2010/586092
– volume: 10
  start-page: 263
  year: 2008
  ident: BFsrep43126_CR43
  publication-title: J Nanopart Res
  doi: 10.1007/s11051-007-9245-3
– volume: 18
  start-page: 788
  year: 2001
  ident: BFsrep43126_CR42
  publication-title: Pharm Res
  doi: 10.1023/A:1011032328064
– volume: 361
  start-page: 2066
  year: 2009
  ident: BFsrep43126_CR1
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra0804647
– volume: 23
  start-page: 170
  year: 2014
  ident: BFsrep43126_CR4
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2014.08.025
– volume: 330
  start-page: 225
  year: 2013
  ident: BFsrep43126_CR12
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2012.11.053
– volume: 52
  start-page: 2015
  year: 2007
  ident: BFsrep43126_CR7
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-006-9622-2
– volume: 3
  start-page: 878
  year: 2007
  ident: BFsrep43126_CR33
  publication-title: Gastroenterology & Hepatology
– volume: 41
  start-page: 1
  year: 2015
  ident: BFsrep43126_CR28
  publication-title: Biofactors
  doi: 10.1002/biof.1195
– volume: 690
  start-page: 3
  year: 2010
  ident: BFsrep43126_CR35
  publication-title: Mutat Res
  doi: 10.1016/j.mrfmmm.2010.03.007
– volume: 56
  start-page: 1240
  year: 2007
  ident: BFsrep43126_CR39
  publication-title: Gut
  doi: 10.1136/gut.2006.118646
– volume: 69
  start-page: 238
  year: 1993
  ident: BFsrep43126_CR44
  publication-title: Lab Invest
– volume: 23
  start-page: 695
  year: 2013
  ident: BFsrep43126_CR2
  publication-title: Gastrointest Endosc Clin N Am
  doi: 10.1016/j.giec.2013.03.006
– volume: 279
  start-page: 71
  year: 2008
  ident: BFsrep43126_CR25
  publication-title: FEMS Microbiol Lett
  doi: 10.1111/j.1574-6968.2007.01012.x
– volume: 14
  start-page: 1597
  year: 2008
  ident: BFsrep43126_CR40
  publication-title: Inflamm Bowel Dis
  doi: 10.1002/ibd.20465
– volume: 89
  start-page: 313
  year: 2010
  ident: BFsrep43126_CR16
  publication-title: Birth Defects Res Part B: Dev Reprod Toxicol
  doi: 10.1002/bdrb.20264
– volume: 76
  start-page: 1485
  year: 2008
  ident: BFsrep43126_CR29
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2008.07.017
– volume: 66
  start-page: 11580
  year: 2006
  ident: BFsrep43126_CR3
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-3562
– volume: 130
  start-page: 1344S
  year: 2000
  ident: BFsrep43126_CR17
  publication-title: The Journal of Nutrition
  doi: 10.1093/jn/130.5.1344S
– volume: 32
  start-page: 904
  year: 2013
  ident: BFsrep43126_CR21
  publication-title: Clin Nutr
  doi: 10.1016/j.clnu.2013.03.020
– volume: 98
  start-page: 694
  year: 1990
  ident: BFsrep43126_CR34
  publication-title: Gastroenterology
  doi: 10.1016/0016-5085(90)90290-H
– volume: 121
  start-page: 1883
  year: 2007
  ident: BFsrep43126_CR15
  publication-title: Int J Cancer
  doi: 10.1002/ijc.22943
– volume: 4
  start-page: 28
  year: 2014
  ident: BFsrep43126_CR31
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2014.00028
– volume: 9
  start-page: 923
  year: 2010
  ident: BFsrep43126_CR9
  publication-title: Nat Mater
  doi: 10.1038/nmat2859
– volume: 17
  start-page: 917
  year: 2011
  ident: BFsrep43126_CR30
  publication-title: Inflamm Bowel Dis
  doi: 10.1002/ibd.21462
– volume: 143
  start-page: 524
  year: 2012
  ident: BFsrep43126_CR5
  publication-title: J Ethnopharmacol
  doi: 10.1016/j.jep.2012.07.008
– volume: 49
  start-page: 160
  year: 2014
  ident: BFsrep43126_CR23
  publication-title: Process Biochem
  doi: 10.1016/j.procbio.2013.10.007
– volume: 690
  start-page: 12
  year: 2010
  ident: BFsrep43126_CR10
  publication-title: Mutat Res
  doi: 10.1016/j.mrfmmm.2009.09.007
– ident: BFsrep43126_CR22
– volume: 55
  start-page: 255
  year: 2015
  ident: BFsrep43126_CR14
  publication-title: Mol Carcinog
  doi: 10.1002/mc.22274
– volume: 135
  start-page: 689
  year: 1999
  ident: BFsrep43126_CR19
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(99)70086-7
– volume: 11
  start-page: 5720
  year: 2014
  ident: BFsrep43126_CR24
  publication-title: Int Environ Res Public Health
  doi: 10.3390/ijerph110605720
– volume: 9
  start-page: e106937
  year: 2014
  ident: BFsrep43126_CR37
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0106937
– volume: 53
  start-page: 1748
  year: 2012
  ident: BFsrep43126_CR18
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2012.08.568
– volume: 448
  start-page: 427
  year: 2007
  ident: BFsrep43126_CR6
  publication-title: Nature
  doi: 10.1038/nature06005
– volume: 443
  start-page: 197
  year: 2002
  ident: BFsrep43126_CR20
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(02)01592-3
– volume: 43
  start-page: 370
  year: 2008
  ident: BFsrep43126_CR36
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2007.10.013
– volume: 11
  start-page: 4366
  year: 2015
  ident: BFsrep43126_CR41
  publication-title: Small
  doi: 10.1002/smll.201500136
– volume: 1
  start-page: 15
  year: 2012
  ident: BFsrep43126_CR38
  publication-title: Am J Gastroenterol
  doi: 10.1038/ajgsup.2012.4
– volume: 1
  start-page: 187
  year: 2008
  ident: BFsrep43126_CR11
  publication-title: Cancer Prev Res (Phila)
  doi: 10.1158/1940-6207.CAPR-08-0028
– reference: 20935658 - Nat Mater. 2010 Nov;9(11):923-8
– reference: 22960578 - Free Radic Biol Med. 2012 Nov 1;53(9):1748-59
– reference: 17404859 - Dig Dis Sci. 2007 Sep;52(9):2015-21
– reference: 19923578 - N Engl J Med. 2009 Nov 19;361(21):2066-78
– reference: 22819687 - J Ethnopharmacol. 2012 Sep 28;143(2):524-32
– reference: 23219897 - Cancer Lett. 2013 Apr 28;330(2):225-32
– reference: 17456510 - Gut. 2007 Sep;56(9):1240-7
– reference: 10801941 - J Nutr. 2000 May;130(5S Suppl):1344S-9S
– reference: 18694732 - Biochem Pharmacol. 2008 Dec 1;76(11):1485-9
– reference: 18421762 - Inflamm Bowel Dis. 2008 Nov;14(11):1597-605
– reference: 20223251 - Mutat Res. 2010 Aug 7;690(1-2):3-11
– reference: 17653185 - Nature. 2007 Jul 26;448(7152):427-34
– reference: 10586170 - J Pediatr. 1999 Dec;135(6):689-97
– reference: 20803691 - Birth Defects Res B Dev Reprod Toxicol. 2010 Aug;89(4):313-25
– reference: 8350599 - Lab Invest. 1993 Aug;69(2):238-49
– reference: 17631644 - Int J Cancer. 2007 Nov 1;121(9):1883-91
– reference: 19138955 - Cancer Prev Res (Phila). 2008 Aug;1(3):187-91
– reference: 15032691 - Curr Pharm Des. 2004;10(8):879-91
– reference: 20645323 - Inflamm Bowel Dis. 2011 Feb;17(2):532-42
– reference: 24879486 - Int J Environ Res Public Health. 2014 May 28;11(6):5720-50
– reference: 25194678 - Int Immunopharmacol. 2014 Nov;23(1):170-8
– reference: 23602613 - Clin Nutr. 2013 Dec;32(6):904-10
– reference: 23735111 - Gastrointest Endosc Clin N Am. 2013 Jul;23(3):695-705
– reference: 25545372 - Biofactors. 2015 Jan-Feb;41(1):1-14
– reference: 21391286 - Inflamm Bowel Dis. 2011 Apr;17(4):917-26
– reference: 20151072 - Can J Gastroenterol. 2010 Feb;24(2):127-33
– reference: 1688816 - Gastroenterology. 1990 Mar;98 (3):694-702
– reference: 19799917 - Mutat Res. 2010 Aug 7;690(1-2):12-23
– reference: 21960801 - Gastroenterol Hepatol (N Y). 2007 Nov;3(11):878-9
– reference: 12044810 - Eur J Pharmacol. 2002 May 17;443(1-3):197-204
– reference: 25598500 - Mol Carcinog. 2016 Mar;55(3):255-67
– reference: 19891667 - Aliment Pharmacol Ther. 2010 Jan 15;31(2):202-9
– reference: 25187953 - PLoS One. 2014 Sep 04;9(9):e106937
– reference: 17178849 - Cancer Res. 2006 Dec 15;66(24):11580-4
– reference: 26097125 - Small. 2015 Sep 9;11(34):4366-78
– reference: 24616886 - Front Cell Infect Microbiol. 2014 Feb 28;4:28
– reference: 18054190 - Exp Gerontol. 2008 May;43(5):370-7
– reference: 11474782 - Pharm Res. 2001 Jun;18(6):788-93
– reference: 18081843 - FEMS Microbiol Lett. 2008 Feb;279(1):71-6
SSID ssj0000529419
Score 2.4939978
Snippet Inflammatory bowel diseases (IBD) are widespread inflammatory diseases that cause debilitating health problems including cancer. In this study, we show that...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 43126
SubjectTerms 13/1
13/21
631/92
64/60
692/4017
82/1
Antioxidants
Cancer
Colon
Dextran
Dextran sulfate
Gastrointestinal tract
Health problems
Homeostasis
Humanities and Social Sciences
IL-1β
Inflammatory bowel disease
Inflammatory bowel diseases
Inflammatory diseases
Intestine
Malondialdehyde
multidisciplinary
Nanoparticles
Peroxidase
Remission
Rodents
Science
Sodium
Sulfates
Tumor necrosis factor
Ulcerative colitis
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Ja90wEB7alEIvoenqZkFdDr2YyJLXUwlZCIWmhzTw6MXIkl7zIJFfYvvw_kZ_cWbkpdnoWYMlPKNZNDPfAHzJU55XNhUhFyYLY5PgnUOzGAoTawyCFFe-y_XHSXp8Fn-fJbPhwa0ZyipHnegVtak1vZHvkuGipGEsvy2vQpoaRdnVYYTGU3hG0GVU0pXNsumNhbJYcVSMgEIy30Wzs0STSVAKt83QA9_yYYnkvTypNz9HL2F98BvZXs_oDXhi3St43k-SXL2Gv7_dT-aUwxB4qHRjSrdMNazpluRio1Jjfa_Vii0cOzg9DTEaR74a1l1o2-N_M-2r4RqioDH1rFqxS7VwbT9Ggv3pWnZeX9oaXcoGyZQztI0fkIbLJ9dzwaggRFGP-xs4Ozr8tX8cDuMWQp3wuA2tVrywJlY5t3MMOxTqUCujihuZapEooeY-cRuZSOc2KioppDGC0FwKdMK4fAtrrnb2PTCVFKbKK4G-ToXxH3I_Mhg3ZlmayDRK0wC-jn-_1AMWOY3EuCh9Tlzm5cSoAD5NpMsegOMxoq2RheVwB5vyn8QE8HFaxttDKRHlbN0hTZ6hzkLCIoB3PcenXTAYlTIr8OPZHVmYCAiZ--6KW5x7hO6EYA4THsDnUWpuHev-4T_8__Cb8EKQK0Ft9PEWrLXXnd1GR6itdry03wAKswuf
  priority: 102
  providerName: ProQuest
– databaseName: SpringerOpen Free (Free internet resource, activated by CARLI)
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Nb9QwEB1BERIXBJTSQEGm5dBLhGMnTnJEC1WFRHtoK1W9RI7tpSu13lWTHPZv8IuZcT5gWw6cPYmtjO15k5l5A_CpULyonRIxFzaPU5vhmUOzGAubGnSCNNehyvXHiTq-SL9fZpcDWXQzpFX2lJbhmh6zwz6jvVihrRPqMTwhxnbazDM1m36nUMAqTcqRO0gWf57YtDgPYOTDbMh7IdFgaY5ewPMBIrIv_aJewiPnX8HTvmnkeht-XflT5rVHb3dYNtOmZbphTbciNI33F-vLqtZs4dnXs7MYHW9UoWXdjXE91TczIfGtIQnqSM_qNbvVC9_2HSPYz65l18tbt0T02KCY9pamCb3QcPjkbi4Y5X5oKmd_DRdH385nx_HQWSE2GU_b2BnNS2dTXXA3Rw9D43XpZFJzK5URmRZ6HmK0iU1M4ZKylkJaK4i4pUS8xeUObPmld7vAdFbauqgFwpoaXT1UdGLRRcxzlUmVKBXB4fj1KzPQjlP3i5sqhL9lUU2KimB_El31XBv_EtobVVgNx62pCNVQRDmVEXychvGgUPRDe7fsUKbI8XpCwTKCN73Gp1nQ75QyL_Hl-cZemASIhHtzxC-uAxl3RoyGGY_gYNw1fy3r_uLf_pfUO3gmCDxQ4Xy6B1vtXefeI_Rp6w9h0_8Ge9oGow
  priority: 102
  providerName: Springer Nature
Title ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling
URI https://link.springer.com/article/10.1038/srep43126
https://www.ncbi.nlm.nih.gov/pubmed/28233796
https://www.proquest.com/docview/1901727243
https://www.proquest.com/docview/1872579019
https://pubmed.ncbi.nlm.nih.gov/PMC5324050
Volume 7
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Li9swEB72QaGX0nfd3Qb1cejFrS3Zsn0oJU13WQKblqaB0EuQLaUbyCrZ2Ibmb_QXd8Yvso-eDNYY2ZoZzYxH8w3Au1h6cWokdz2uIzfQIeocmkWX6yDDIEh5qqpyPR_Js0kwnIbTPWh7bDYLmN8Z2lE_qclm-eHP1fYzKvynumQ8_oi2ZI12kMt9OESDFJF-njdefg3xzZPAT1pcod0nCAs45kJEBNq_a5hueZu3D03eyJxWBun0ITxoPEnWr1n_CPaMfQz36t6S2yfw95f9xqyyGBQ3Z9-YygqmcpaXa_pe3OZYXX21ZQvLvo7HLsbnyGnNymVmakRwllXn43KioMb1LN2yS7WwRd1Ygv0uC3axujQrdDJzJFNW0zRVyzQcHm3mnNEREUVV709hcnryc3DmNg0Y3Cz0gsI1mfISowMVe2aOgYjCXdUIP_W0kBkPFVfzKpXraz-LjZ-kggutOeG7JOiWeeIZHNiVNS-AqTDRaZxy9H5SjAhRHnyNkWQUyVBIX0oH3rerP8sadHJqkrGcVVlyEc86njnwpiNd15AcdxEdtyyctUI1I-eHEs-BcOB1N4z6REkSZc2qRJo4wl0MCRMHntcc72ZpRcWB6JosdASE1X19xC4uKszukIAPQ8-Bt63U7LzWzZd_-d-Zj-A-J7-CauqDYzgoNqV5hV5RkfZgP5pGPTjs94fjIV6_nIy-_8C7AznoVX8aepVW_AMklRN6
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Zb9QwEB6VrRB9QdwECphL4iVqYud8QAhoqy1tF0RbqeIlOLa3XanrLE1WaP8GP4TfyEwueiDe-uyRbWXGc2RmvgF4lURekpuIux7XsRvoEN8cmkWX60BhECQ9WXe57o6i4UHw6TA8XILfXS8MlVV2OrFW1LpQ9I98jQwXJQ0D8W72w6WpUZRd7UZoNGKxbRY_MWQr326tI39fc765sf9x6LZTBVwVekHlGiW91OhAJp4Zo3ctUVUY4eeeFpHioeRyXOcnfe2rxPhpLrjQmhNoSYq-hidw32uwHAgMZQaw_GFj9OVr_1eH8maBn3YQRiJZQ0M3QyNN4A1nDd8lb_ZyUeaFzGxt8DZvwc3WU2XvG9G6DUvG3oHrzezKxV349c1-ZlZaDLrb2jomVcVkycr5jJx6VKOs6e5asIll63t7Lsb_KEmazU-UaRDHmarr70qimKLOYvmCTeXEVs3gCnY0r9hxMTUFOrElkkmr6Zh6JBsuj07HnFEJiqSu-ntwcCWsuA8DW1jzEJgMU50nOUfvKseIE-XN1xipxnEUisiPIgfedF8_Uy36OQ3hOMnqLLxIsp5RDrzoSWcN5Me_iFY7Fmbtqy-zvzLqwPN-Gd8rJWGkNcUcaZIYtSQSpg48aDjen4LhrxBxipvH52ShJyAs8PMrdnJcY4KHBKwYeg687KTmzLUuXv7R_y__DG4M93d3sp2t0fZjWOHkyFATf7AKg-p0bp6gG1blT1vZZ_D9qp_bH7IaSJg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3JbtRAEC2FIBAXxI4hQLNJXKyxu70eEEIMo4TAgBQijXIx7e4eMlKmPcS20PwGn8PXUeWNLIhbzl2yW67dVfUK4EUSeUluIu56XMduoEPUOXSLLteBwiRIerKZcv00jbb3gw-zcLYBv_tZGGqr7G1iY6h1oegf-YgcFxUNAzGad20RX8aTN6sfLm2Qokprv06jFZFds_6J6Vv5emeMvH7J-eT913fbbrdhwFWhF1SuUdJLjQ5k4pk5RtoSzYYRfu5pESkeSi7nTa3S175KjJ_mggutOQGYpBh3eAKfewkuxyL0ScfiWTz836EKWuCnPZiRSEbo8lborgnG4aQLPBfXnm_PPFOjbVzf5AZc72JW9rYVspuwYewtuNJusVzfhl8H9jOz0mL63XXZMakqJktW1isK79GgsnbOa80Wlo339tyF1ShTmtVHyrTY40w1nXglUSzRerF8zZZyYat2hQX7XlfssFiaAsPZEsmk1fSaZjkbHk-P55xRM4qk-fo7sH8hjLgLm7aw5j4wGaY6T3KOcVaOuSdKnq8xZ43jKBSRH0UOvOq_fqY6HHRax3GUNfV4kWQDoxx4NpCuWvCPfxFt9SzMOv0vs7_S6sDT4Rg1l8ox0pqiRpokRnuJhKkD91qOD2_BRFiIOMWHx6dkYSAgVPDTJ3Zx2KCDhwSxGHoOPO-l5sS1zl7-wf8v_wSuopJlH3emuw_hGqeIhqb5gy3YrI5r8wjjsSp_3Ag-g28XrWl_ACmpS2g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ZnO+nanoparticles+act+as+supportive+therapy+in+DSS-induced+ulcerative+colitis+in+mice+by+maintaining+gut+homeostasis+and+activating+Nrf2+signaling&rft.jtitle=Scientific+reports&rft.au=Li%2C+Jinquan&rft.au=Chen%2C+Hanqing&rft.au=Wang%2C+Bing&rft.au=Cai%2C+Chengxu&rft.date=2017-02-24&rft.eissn=2045-2322&rft.volume=7&rft.spage=43126&rft_id=info:doi/10.1038%2Fsrep43126&rft_id=info%3Apmid%2F28233796&rft.externalDocID=28233796
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon